TTOO Cost of Revenue vs Receivables Turnover Analysis

TTOO Stock  USD 3.00  0.05  1.64%   
T2 Biosystms financial indicator trend analysis is much more than just breaking down T2 Biosystms prevalent accounting drivers to predict future trends. We encourage investors to analyze account correlations over time for multiple indicators to determine whether T2 Biosystms is a good investment. Please check the relationship between T2 Biosystms Cost Of Revenue and its Receivables Turnover accounts. Check out World Market Map to better understand how to build diversified portfolios, which includes a position in T2 Biosystms. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in persons.
To learn how to invest in TTOO Stock, please use our How to Invest in T2 Biosystms guide.

Cost Of Revenue vs Receivables Turnover

Cost of Revenue vs Receivables Turnover Correlation Analysis

The overlapping area represents the amount of trend that can be explained by analyzing historical patterns of T2 Biosystms Cost of Revenue account and Receivables Turnover. At this time, the significance of the direction appears to have significant contrarian relationship.
The correlation between T2 Biosystms' Cost of Revenue and Receivables Turnover is -0.41. Overlapping area represents the amount of variation of Cost of Revenue that can explain the historical movement of Receivables Turnover in the same time period over historical financial statements of T2 Biosystms, assuming nothing else is changed. The correlation between historical values of T2 Biosystms' Cost of Revenue and Receivables Turnover is a relative statistical measure of the degree to which these accounts tend to move together. The correlation coefficient measures the extent to which Cost of Revenue of T2 Biosystms are associated (or correlated) with its Receivables Turnover. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when Receivables Turnover has no effect on the direction of Cost of Revenue i.e., T2 Biosystms' Cost of Revenue and Receivables Turnover go up and down completely randomly.

Correlation Coefficient

-0.41
Relationship DirectionNegative 
Relationship StrengthVery Weak

Cost Of Revenue

Cost of Revenue is found on T2 Biosystms income statement and represents the costs associated with goods and services T2 Biosystms provides. Indirect cost, such as salaries, is not included. In other words, cost of revenue is the total cost incurred to obtain a sale. It is more than the traditional cost of goods sold, since it includes specific selling and marketing activities.

Receivables Turnover

Most indicators from T2 Biosystms' fundamental ratios are interrelated and interconnected. However, analyzing fundamental ratios indicators one by one will only give a small insight into T2 Biosystms current financial condition. On the other hand, looking into the entire matrix of fundamental ratios indicators, and analyzing their relationships over time can provide a more complete picture of the company financial strength now and in the future. Check out World Market Map to better understand how to build diversified portfolios, which includes a position in T2 Biosystms. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in persons.
To learn how to invest in TTOO Stock, please use our How to Invest in T2 Biosystms guide.As of the 28th of March 2024, Selling General Administrative is likely to drop to about 26 M. In addition to that, Issuance Of Capital Stock is likely to drop to about 45 M
 2021 2022 2023 2024 (projected)
Interest Expense6.6M6.1M5.7M5.0M
Depreciation And Amortization318K39K35.1K33.3K

T2 Biosystms fundamental ratios Correlations

0.450.260.110.880.160.55-0.24-0.240.10.750.550.370.170.40.840.240.050.17-0.450.330.35-0.60.550.90.01
0.450.810.370.340.650.950.63-0.920.54-0.040.89-0.30.620.870.050.820.040.37-0.380.90.99-0.260.950.20.21
0.260.810.780.240.270.680.54-0.780.7-0.070.58-0.230.330.7-0.040.540.460.56-0.650.630.8-0.280.680.080.64
0.110.370.780.18-0.220.230.2-0.340.380.060.120.05-0.150.220.020.050.810.57-0.780.090.35-0.270.230.070.96
0.880.340.240.18-0.150.4-0.42-0.050.010.830.370.51-0.040.30.89-0.010.290.18-0.650.180.23-0.80.40.920.16
0.160.650.27-0.22-0.150.650.78-0.790.31-0.440.7-0.590.860.57-0.330.95-0.63-0.030.240.790.690.110.65-0.21-0.41
0.550.950.680.230.40.650.54-0.830.520.050.95-0.140.550.810.160.77-0.020.26-0.290.820.92-0.241.00.30.06
-0.240.630.540.2-0.420.780.54-0.830.54-0.780.56-0.650.640.54-0.70.85-0.220.260.050.690.70.220.54-0.580.02
-0.24-0.92-0.78-0.34-0.05-0.79-0.83-0.83-0.610.33-0.80.54-0.73-0.820.24-0.930.1-0.370.23-0.9-0.950.06-0.830.08-0.15
0.10.540.70.380.010.310.520.54-0.61-0.290.51-0.170.270.61-0.190.490.130.59-0.20.590.560.040.52-0.070.23
0.75-0.04-0.070.060.83-0.440.05-0.780.33-0.29-0.040.56-0.26-0.030.96-0.390.29-0.1-0.42-0.21-0.15-0.560.050.920.11
0.550.890.580.120.370.70.950.56-0.80.51-0.04-0.030.480.760.140.79-0.160.38-0.180.830.87-0.170.950.28-0.03
0.37-0.3-0.230.050.51-0.59-0.14-0.650.54-0.170.56-0.03-0.77-0.330.64-0.580.350.22-0.2-0.44-0.37-0.21-0.140.590.18
0.170.620.33-0.15-0.040.860.550.64-0.730.27-0.260.48-0.770.54-0.250.86-0.54-0.230.040.740.63-0.140.55-0.14-0.36
0.40.870.70.220.30.570.810.54-0.820.61-0.030.76-0.330.540.050.730.030.5-0.270.860.88-0.210.810.20.07
0.840.05-0.040.020.89-0.330.16-0.70.24-0.190.960.140.64-0.250.05-0.280.20.04-0.38-0.08-0.05-0.540.160.990.06
0.240.820.540.05-0.010.950.770.85-0.930.49-0.390.79-0.580.860.73-0.28-0.410.18-0.030.890.84-0.040.77-0.13-0.17
0.050.040.460.810.29-0.63-0.02-0.220.10.130.29-0.160.35-0.540.030.2-0.410.44-0.75-0.290.0-0.37-0.020.180.87
0.170.370.560.570.18-0.030.260.26-0.370.59-0.10.380.22-0.230.50.040.180.44-0.380.360.39-0.030.260.140.56
-0.45-0.38-0.65-0.78-0.650.24-0.290.050.23-0.2-0.42-0.18-0.20.04-0.27-0.38-0.03-0.75-0.38-0.1-0.310.81-0.29-0.42-0.72
0.330.90.630.090.180.790.820.69-0.90.59-0.210.83-0.440.740.86-0.080.89-0.290.36-0.10.92-0.090.820.08-0.07
0.350.990.80.350.230.690.920.7-0.950.56-0.150.87-0.370.630.88-0.050.840.00.39-0.310.92-0.160.920.10.19
-0.6-0.26-0.28-0.27-0.80.11-0.240.220.060.04-0.56-0.17-0.21-0.14-0.21-0.54-0.04-0.37-0.030.81-0.09-0.16-0.24-0.55-0.2
0.550.950.680.230.40.651.00.54-0.830.520.050.95-0.140.550.810.160.77-0.020.26-0.290.820.92-0.240.30.06
0.90.20.080.070.92-0.210.3-0.580.08-0.070.920.280.59-0.140.20.99-0.130.180.14-0.420.080.1-0.550.30.08
0.010.210.640.960.16-0.410.060.02-0.150.230.11-0.030.18-0.360.070.06-0.170.870.56-0.72-0.070.19-0.20.060.08
Click cells to compare fundamentals

T2 Biosystms Account Relationship Matchups

T2 Biosystms fundamental ratios Accounts

201920202021202220232024 (projected)
Total Assets28.5M79.1M60.5M34.4M39.5M62.0M
Short Long Term Debt Total44.8M55.8M57.1M59.2M68.1M40.9M
Other Current Liab13.6M6.4M7.2M7.7M8.8M6.6M
Total Current Liabilities60.6M9.8M11.7M10.5M12.1M23.0M
Total Stockholder Equity(34.0M)8.7M(12.9M)(40.0M)(46.0M)(43.7M)
Other Liab46K4.8M4.6M4.9M5.6M5.9M
Property Plant And Equipment Net9.2M14.8M14.4M13.3M15.3M9.8M
Net Debt33.7M39.0M34.9M48.9M56.2M59.0M
Retained Earnings(376.2M)(423.0M)(472.2M)(534.5M)(481.1M)(457.0M)
Accounts Payable3.8M2.1M2.8M1.3M1.5M1.6M
Cash11.0M16.8M22.2M10.3M9.3M8.8M
Non Current Assets Total9.6M25.5M16.1M15.0M17.2M11.7M
Cash And Short Term Investments11.0M42.2M32.2M10.3M9.3M8.8M
Common Stock Total Equity36K44K51K147K169.1K177.5K
Common Stock Shares Outstanding455.1K24.3K31.8K51.0K58.7K55.7K
Liabilities And Stockholders Equity28.5M79.1M60.5M34.4M39.5M62.0M
Non Current Liabilities Total1.9M60.6M61.8M63.9M57.5M34.1M
Other Current Assets1.4M2.7M3.1M2.6M3.0M1.5M
Other Stockholder Equity342.1M431.5M459.2M494.6M568.7M288.0M
Total Liab62.5M70.4M73.4M74.4M66.9M50.8M
Property Plant And Equipment Gross9.2M14.8M14.4M13.3M15.3M9.8M
Total Current Assets18.9M53.6M44.4M19.4M17.5M16.6M
Accumulated Other Comprehensive Income(11.3M)(13.2M)9K(4K)(3.6K)(3.8K)
Short Term Debt42.9M1.2M1.2M1.4M1.6M1.5M
Common Stock49K147K166K8K9.2K8.7K
Property Plant Equipment5.8M14.8M14.4M13.3M15.3M9.5M
Net Tangible Assets(32.1M)8.7M(12.9M)(40.0M)(36.0M)(34.2M)
Current Deferred Revenue285K230K518K172K154.8K147.1K
Net Receivables2.8M5.1M5.1M2.2M2.5M2.2M
Retained Earnings Total Equity(266.1M)(317.2M)(376.2M)(423.0M)(380.7M)(399.7M)
Capital Surpluse267.4M328.5M342.1M431.5M496.3M308.8M
Inventory3.6M3.6M3.9M4.3M5.0M2.6M
Capital Lease Obligations3.9M10.5M9.4M9.6M11.0M5.7M

Currently Active Assets on Macroaxis

When determining whether T2 Biosystms offers a strong return on investment in its stock, a comprehensive analysis is essential. The process typically begins with a thorough review of T2 Biosystms' financial statements, including income statements, balance sheets, and cash flow statements, to assess its financial health. Key financial ratios are used to gauge profitability, efficiency, and growth potential of T2 Biosystms Stock. Outlined below are crucial reports that will aid in making a well-informed decision on T2 Biosystms Stock:
Check out World Market Map to better understand how to build diversified portfolios, which includes a position in T2 Biosystms. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in persons.
To learn how to invest in TTOO Stock, please use our How to Invest in T2 Biosystms guide.
You can also try the Efficient Frontier module to plot and analyze your portfolio and positions against risk-return landscape of the market..

Complementary Tools for TTOO Stock analysis

When running T2 Biosystms' price analysis, check to measure T2 Biosystms' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy T2 Biosystms is operating at the current time. Most of T2 Biosystms' value examination focuses on studying past and present price action to predict the probability of T2 Biosystms' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move T2 Biosystms' price. Additionally, you may evaluate how the addition of T2 Biosystms to your portfolios can decrease your overall portfolio volatility.
Volatility Analysis
Get historical volatility and risk analysis based on latest market data
Portfolio Dashboard
Portfolio dashboard that provides centralized access to all your investments
Price Exposure Probability
Analyze equity upside and downside potential for a given time horizon across multiple markets
Watchlist Optimization
Optimize watchlists to build efficient portfolios or rebalance existing positions based on the mean-variance optimization algorithm
AI Portfolio Architect
Use AI to generate optimal portfolios and find profitable investment opportunities
Global Markets Map
Get a quick overview of global market snapshot using zoomable world map. Drill down to check world indexes
Portfolio Anywhere
Track or share privately all of your investments from the convenience of any device
Is T2 Biosystms' industry expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of T2 Biosystms. If investors know TTOO will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about T2 Biosystms listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share
(35.62)
Revenue Per Share
7.933
Quarterly Revenue Growth
(0.60)
Return On Assets
(0.68)
Return On Equity
(6.22)
The market value of T2 Biosystms is measured differently than its book value, which is the value of TTOO that is recorded on the company's balance sheet. Investors also form their own opinion of T2 Biosystms' value that differs from its market value or its book value, called intrinsic value, which is T2 Biosystms' true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because T2 Biosystms' market value can be influenced by many factors that don't directly affect T2 Biosystms' underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between T2 Biosystms' value and its price as these two are different measures arrived at by different means. Investors typically determine if T2 Biosystms is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, T2 Biosystms' price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.